Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse
Clinical trial NCT05706038 · COMPLETED
Trial details
- NCT number
- NCT05706038
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-27
- Primary completion
- 2022-10-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.